✦ LIBER ✦

Differential Modulation of the Expression of the Intermediate Filament Proteins Vimentin and Nuclear Lamins A and C by Differentiation Inducers in Human Myeloid Leukemia (U-937, HL-60) Cells

✍ Scribed by Carlos Rius; Nuria Vilaboa; Felicı́sima Mata; Patricio Aller

Book ID: 115601540
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 414 KB
Volume: 208
Category: Article
ISSN: 0014-4827
DOI: 10.1006/excr.1993.1228

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human EVI9, a Homologue of the Mouse Mye

Human EVI9, a Homologue of the Mouse Myeloid Leukemia Gene, Is Expressed in the Hematopoietic Progenitors and Down-Regulated during Myeloid Differentiation of HL60 Cells

✍ Yuriko Saiki; Yukari Yamazaki; Michihiro Yoshida; Osamu Katoh; Takuro Nakamura 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Modulation of Protein Kinase C Activity

Modulation of Protein Kinase C Activity and Calcium-Sensitive Isoform Expression in Human Myeloid Leukemia Cells by Bryostatin 1: Relationship to Differentiation and Ara-C-Induced Apoptosis

✍ Steven Grant; Amy J. Turner; Alex J. Freemerman; Zhiliang Wang; Lora Kramer; W.D 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 783 KB

Alteration of intracellular actin levels

Alteration of intracellular actin levels induced by phorboldiester in human HL-60 leukemia cells susceptible or resistant to differentiation, and the effects of protein kinase inhibitors

✍ Yasuhiro Uemura; Masakatsu Nishikawa; Fumihiko Komada; Shigeru Shirakawa 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 585 KB

Resistance to 1,25D-induced differentiat

Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor

✍ Edward Garay; Robert Donnelly; Xuening Wang; George P. Studzinski 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

## Abstract The anti‐neoplastic effects of 1,25‐dihydroxyvitamin D~3~ (1,25D) are well documented in numerous tumor cell systems and animal models of cancer. However, despite this pre‐clinical success, the clinical use of 1,25D is currently impeded by the dose‐limiting hypercalcemia, and the risk o